@misc{10481/83885,
year = {2023},
month = {2},
url = {https://hdl.handle.net/10481/83885},
abstract = {Objective: To examine the efficacy and safety of non-pharmacological and non-ablative options (or a combination of these) for postmenopausal
dyspareunia. Mechanism: Narrative review on non-pharmacological and non-ablative options (or a combination of these)
for postmenopausal dyspareunia. Findings in Brief: Dyspareunia is the most bothersome symptom of the genitourinary syndrome
of menopause, often complicated by decreased sexual interest and arousal. Solid-state vaginal laser (SSVL) and recombinant plateletderived
epidermal growth factors (RGFs) are new alternatives are new alternatives that improve female sexual dysfunction resulting from
dyspareunia. Conclusions: SSVL is a new alternative the treatment of postmenopausal dyspareunia either alone or in combination with
other alternatives with efficacy and safety similar to the classical options.},
publisher = {IMR Press},
keywords = {Female sexual dysfunction},
keywords = {Genitourinary syndrome of menopause},
keywords = {Dyspareunia},
keywords = {Solid-state vaginal laser},
keywords = {Epidermal growth factor},
title = {Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility?},
doi = {doi.org/10.31083/j.ceog5002040},
author = {Mendoza Ladrón De Guevara, Nicolás and Quereda, Francisco},
}